Latest Content

Presentations focused on the efficacy of long-acting cabotegravir, doravirine/islatravir, and bictegravir/lenacapavir when used as antiretroviral therapy.

MASLD and type 2 diabetes are closely interconnected conditions driven by shared metabolic dysfunction that together increase the risk of liver disease progression, cardiovascular complications, and mortality.

Abstracts presented during the Conference on Retroviruses and Opportunistic Infections 2026 offered a glimpse into which therapies patients prefer to use to treat HIV.

The ready-to-use formulation supports clinicians and families by addressing historical administration challenges.

Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

Nurse understaffing linked to higher in-hospital mortality, 30-day readmissions, and longer stays.

New data show Chicago’s South Side Level 1 trauma center cuts gunshot travel times and lowers firearm deaths, highlighting equity gains.

Kevin Ma, PhD, discusses new data showing 2024–2025 COVID-19 vaccines reduced hospitalization and severe outcomes.

The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone.